Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VanEck Vectors Biotech ETF (BBH)

Delayed Data
As of May 03
 -1.92 / -1.79%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors  US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.


1 month+1.01% 3 years+15.21%
3 months+8.03% 5 years--
1 year-16.27% Since inception+29.19%
Data through 05/03/2016

Quote Details

Previous close$107.29
Open day’s range105.22 – 106.70
Net asset value (NAV)107.31 (05/02/2016)
Daily volume59,163
Average volume (3 months)108,172
Data as of 4:00pm ET, 05/03/2016

Peer Comparisonvs. Health ETFs

Performance 5-yr return--+15.78%
Expense Gross exp ratio0.41%0.47%
Risk 5 year sharpe ratio--1.00
Net assets$518.4M$1.2B
Average market cap$27.4B$28.1B
Average P/E18.922.4
Dividend / Share--0.22%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
GILD Gilead Sciences13.32%
AMGN Amgen11.85%
CELG Celgene9.38%
BIIB Biogen5.59%
REGN Regeneron Pharmaceuticals5.19%
BXLT Baxalta Inc4.95%
ILMN Illumina Inc4.68%
INCY Incyte Corp4.61%
ALXN Alexion Pharmaceuticals Inc4.37%
BMRN Biomarin Pharmaceutical Inc4.26%

Partner Offers

Search for Jobs